Using a dye to guide sarcoma surgery
Part of Cancer clinical trials.
This trial tests a special dye that helps surgeons see the edges of sarcoma tumors during surgery. It may help them remove all the cancer while saving healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your sarcoma is moderate or high grade (confirmed by biopsy)
- The tumor is in an arm, leg, or the wall of your trunk
- Your doctor plans to remove the tumor with surgery (aiming for a cure)
- You are not allergic to iodine-based medications
- You do not have severe kidney disease or need dialysis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special dye and imaging technique to help surgeons see and remove sarcoma tumors more completely. The goal is to reduce the chance that cancer cells are accidentally left behind during surgery.
This Phase 2 study tests whether using a fluorescent dye during tumor surgery can help the surgical team better see where the tumor ends. It may help aim for complete removal and lower the chance of the tumor coming back.
This trial tests a new type of radiation called spatially fractionated radiation therapy (SFRT) given before surgery for large soft tissue sarcomas in the arm, leg, or trunk. The goal is to see if it helps shrink the tumor and improve treatment outcomes.
This study tests whether using a special dye during surgery helps doctors see and remove sarcoma tumors more completely. It may help improve the chances that no cancer is left behind.
This trial tests if taking a drug called 5-ALA before surgery makes sarcoma tumors glow, helping surgeons remove all cancer cells. It's for people with certain types of soft tissue sarcoma that are more aggressive (grades 2 or 3) and are scheduled for surgery.
This trial tests whether a fluorescent dye applied to tissue during surgery helps doctors see tumors and check if the tumor removal is complete. If you have a solid tumor and are scheduled for surgery, this study may improve the precision of your operation.
Hear when a new Soft Tissue Sarcoma of the Trunk and Extremities trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.